Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This annual and popular course provides a thorough grounding in the principles and practice of randomised controlled trials (RCTs) for the evaluation of healthcare interventions. It includes talks and practicals, and provides guidance on the methodology of trials using a problem-based learning approach.

Logo for the Centre for Statistics in Medicine

Course objectives

Clarify fundamental principles and practice of RCTs

* Demonstrate the optimal methodology to use in RCTs based on considerable practical experience and by using numerous examples from the literature

* Examine the critical issues involved in planning, conducting, analysing and reporting a successful trial

* Provide a basic understanding of statistical input into RCTs including analyses frequently used

* Facilitate critical appraisal of RCTs

 Who should attend?

The course is aimed at individuals who are actively involved in trials or planning to be also those interested in furthering their knowledge of trial methodology. Applications are invited from clinical and non-clinical researchers and other professionals allied to medicine. The course provides an overview of clinical trials and would benefit individuals early in their career or serve as a refresher for more experienced individuals.

Applications forms and a further information can be obtained by emailing:

rct.course@csm.ox.ac.uk

Or by telephoning CSM on Tel: +44(0)1865 223447     

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.